FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Garner is a behavioral intervention scientist and an assistant professor of nutritional sciences.
More than 5,900 bags of this Marketside Broccoli were sold. The states that are currently impacted by this recall are the ...
Now that the U.S. Food and Drug Administration has banned Red Dye No. 3, artificial food dyes are under increasing scrutiny.
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
PLU codes do more than scan at checkout — they reveal how your fruits and vegetables were grown. And understanding those ...
The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...
The recalled Broccoli that was sold at Walmart locations in 20 states has been elevated to the highest level status by the ...
Last month, the FDA announced a recall for multiple products from Cal Yee Farm including chocolate and yogurt covered products.
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback